Japan reimburses single-use medical devices based on their classification, clinical benefits, and cost-effectiveness under the NHI system. Pricing is determined by Chuikyo, considering manufacturing costs and healthcare impact. Reimbursement encourages cost control while ensuring patient safety. Innovative single-use devices may qualify for premium pricing if they offer significant clinical advantages.
